Wissenschaftliche Publikationen

Wissenschaftliche Arbeiten unserer Fachärzte

2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006


 

2015


FACE 4-2015: Bunert, Roth, Dr. Hilton, Da Mota; Kryolipolyse – Eine hochwirksame nichtinvasive Methode der Fettreduktion

Akpata R, Neumayr A, Holtfreter MC, Krantz I, Singh DD, Mota R, Walter S, Hatz C, Richter J. The WHO ultrasonography protocol for assessing morbidity due to Schistosoma haematobium. Acceptance and evolution over 14 years. Systematic review. Parasitol Res. 2015 Feb

2014


El Scheich T, Holtfreter MC, Ekamp H, Singh DD, Mota R, Hatz C,  Richter J. The WHO ultrasonography protocol for assessing hepatic morbidity due to Schistosoma mansoni. Acceptance and evolution over 12 years. Parasitol Res. 2014 Nov

 

Ehmann LM, Reinholz M, Meier T, Lang M, Wollenerg A. Toleriane Fluid efficacy in perioral dermatitis-results of the TOLPOD study. Ann Dermatol. 2014 Aug

 

Philipp-Dormston WG, Hilton S, Nathan M A prospective, open-label, multicenter, observational, postmarket study of the use of a 15 mg/mL hyaluronic acid dermal filler in the lips. J Cosmet Dermatol. 2014 Jun

 

Bafaraj MG, Cesko E, Weindorf M, Dissemond J. Chronic leg ulcers as a rare cause for the first diagnosis of epidermolysis bullosa dystrophica. Int Wound J. 2014 Jun

 

Ehmann LM, Schrumpf H, Gerber PA, Homey B. Drug reactions caused by chemotherapy agents. Hautarzt. 2014 May

 

Hilton S, Schrumpf H, Buhren BA, Bölke E, Gerber PA. Hyaluronidase injection for the treatment of eyelid edema: a retrospective analysis of 20 patients. Eur J Med Res. 2014 May

 

Philipp-Dormston WG, Eccleston D, De Boulle K, Hilton S, van den Elzen H, Nathan M.A prospective, observational study of the volumizing effect of open-label aesthetic use of Juvéderm® VOLUMA® with Lidocaine in mid-face area. J Cosmet Laser Ther. 2014 May

 

2013


Hilton S, Heise H, Buhren BA, Schrumpf H, Bölke E, Gerber PA. Treatment of melasma in Caucasian patients using a novel 694-nm Q-switched ruby fractional laser. Eur J Med Res. 2013 Nov

 

Groesser L, Herschberger E, Sagrera A, Shwayder T, Flux K, Ehmann L, Wollenberg A, Torrelo A, Bagazgoitia L, Diaz-Ley B, Tinschert S, Oschlies I, Singer S, Mickler M, Toll A, Landthaler M, Real FX, Hafner C.; Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent progenitor cell. J Invest Dermatol. 2013 Aug

 

Ehmann LM, Meller S, Homey B.; Successful treatment of granulomatous rosacea with dapsone. Hautarzt. 2013 Apr

 

Tillack C, Ehmann LM, Glas J, Wetzke M, Ochsenkühn T, Czamara D, Diegelmann J, Wollenberg A, Brand S; Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are modulated by IL23R gene variants and respond to anti-IL-12/IL-23 antibody treatment. Gut. 2013 Mar 6

 

Tillack C, Ehmann LM, Glas J, Wetzke M, Ochsenkühn T, Czamara D, Diegelmann J, Wollenberg A, Brand S; Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are modulated by IL23R gene variants and respond to anti-IL-12/IL-23 antibody treatment. Gut. 2013 Mar

 

Rzany B, Fratila AA, Fischer TC, Hilton S, Pavicic T, Rothhaar A, Sattler G, Sommer B, Pickett A. Recommendations for the best possible use of botulinum neurotoxin type a (Speywood units) for aesthetic applications. J Drugs Dermatol. 2013 Jan

 

2012


Grahovac M, Ehmann LM, Flaig M, Wollenberg A (2011) Neutrophilic eccrine hidradenitis induced by cytarabine. Acta Dermatovenerol Croat. 2012 Dec

 

Moers-Carpi M, Dirschka T, Feller-Heppt G, Hilton S, Hoffmann K, Philipp-Dormston WG, Rütter A, Tan K, Chapman MA, Fulford-Smith A. A randomised, double-blind comparison of 20 units of onabotulinumtoxinA with 30 units of incobotulinumtoxinA for glabellar lines. J Cosmet Laser Ther. 2012 Dec

 

Wollenberg A, Ehmann LM; Proactive therapy and other long-term concepts for the treatment of atopic eczema. Ann Dermatol. 2012 Aug

 

Mokosch A, Mota R, Gerber PA, Homey B. Severe toxic dermatitis after injection lipolysis. Hautarzt. 2012 Apr;63(4):282-5

 

Gerber PA, Meller S, Eames T, Buhren BA, Schrumpf H, Hetzer S, Ehmann LM, Bölke E, Wollenberg A, Homey B. Management of EGFR-inhibitor associated rash: A retrospective study in 49 patients Eur J Med Res. 2012 Feb

 

2011


Ehmann LM, Grahovac M, Kramer M, Ruzicka T, Wollenberg A (2011) Paraneoplastische palmoplantare Hyperkeratose: Minorform der Acrokeratosis paraneoplastica Bazex? Hautarzt. 2011 Dec

 

Mota R, Reifenberger J, Homey B, Bruch-Gerharz D. Malassezia folliculitis in an immunocompromised patient. Hautarzt. 2011 Oct

 

Mokosch A, Bernecker C, Willenberg HS, Neumann NJ. Kallmann syndrome. Hautarzt. 2011 Oct

 

Ehmann LM, Tillack S, Brand S, Wollenberg A (2011) Malignant melanoma during ustekinumab therapy of Crohn’s disease. Inflamm Bowel Dis. 2011 Oct

 

Ehmann LM, Heinemann V, Wollenberg A (2011) Neue Tyrosinkinase- und EGFR Inhibitoren in der Tumortherapie; Herz und Haut als wichtige Schädigungsorgane. Teil B: Haut. Internist (Berl). 2011 Jul

 

Ehmann LM, Fiegl M, Wollenberg A (2011) Multiple Sister Mary Joseph’s Nodules bei Magenkrebs: ein Fallbericht. Dtsch Med Wochenschr. 2011 Jun 14

 

Mühlenstädt E, Mokosch A, Homey B, Reifenberger J. Erythema elevatum et diutinum. Hautarzt. 2011 Apr

 

Hilton S, Reinerth G, Heise H, Buhren BA, Bölke E, Gerber PA. Hypopigmented scar formation after application of over-the-counter wart and mole removal cream. Wien Klin Wochenschr. 2011 Mar

 

Bölke E, Schieren G, Gripp S, Steinbach G, Peiper M, Orth K, Matuschek C, Pelzer M, Lammering G, Houben R, Antke C, Rump LC, Mota R, Gerber PA, Schuler P, Hoffmann TK, Rusnak E, Hermsen D, Budach W. Cystatin C – a fast and reliable biomarker for glomerular filtration rate in head and neck cancer patients. Strahlenther Onkol. 2011 Mar

 

Fleischmann F, Matuschek C, Orth K, Gerber PA, Mota R, Knoefel WT, Peiper M, Schick M, van Griensven M, Bölke E, Fleischmann W. Aprotinin and classic wound drainage are unnecessary in total hip replacement – a prospective randomized trial. Eur J Med Res. 2011 Jan

 

Ehmann LM, Ruzicka T, Wollenberg A Cutaneous side-effects of EGRF inhibitors and their management. Skin Therapy Lett. 2011 Jan

 

2010


Marquardt C, Matuschek E, Bölke E, Gerber PA, V Seydlitz-Kurzbach J, Buhren BA, van Griensven M, Budach W, Hassan M, Kukova G, Mota R, Orth K, Fleischmann W : Evaluation of the tissue toxicity of antiseptics by the hen’s egg test on the chorioallantoic membrane (HETCAM) Eur J Med Res. 2010

Mota R, Reifenberger J, Hanneken S, Mühlenstädt E. Classical and atypical   presentations of Galli-Galli disease. Hautarzt 2010

 

Rzany B, Hilton S, Prager W, Hartmann V, Brandl G, Fischer TC, Gekeler O, Glöckner S, Gramlich G, Hartmann M, Lederman K, Luckner-Neugebauer J, Pavicic T, Stangl S, Walker T, Zenker S, Wolters M. Expert guideline on the use of porcine collagen in aesthetic medicine. J Dtsch Dermatol Ges. 2010

 

2009


Bölke E, Orth K, Gerber PA, Lammering G, Mota R, Peiper M, Matuschek C, Budach W, Rusnak E, Shaikh S, Dogan B, Prisack HB, Bojar H. Gene expression of circulating tumour cells in breast cancer patients. Eur J Med Res. 2009

 

Bölke E, Orth K, Gerber PA, Lammering G, Mota R, Peiper M, Matuschek C, Budach W, Rusnak E, Shaikh S, Dogan B, Prisack HB, Bojar H. Gene expression of circulating tumour cells and its correlation with tumour stage in breast cancer patients. Eur J Med Res. 2009

 

2008


Hoff NP, Groffik A, Mota R, Pippirs U, Hengge UR, Kobbe G, Homey B, Bruch-Gerharz D (2008) Successful use of allogeneic stem cell transplantation for treatment-refractory mycosis fungoides. Hautarzt 2008

 

Hoff NP, Mota R, Groffik A, Hengge UR. (2008) Cutaneous larva migrans. Hautarzt 2008

 

2007


Nambiar S, Mirmohammadsadegh A, Hassan M, Mota R, Marini A, Alaoui A, Tannapfel A, Hegemann JH, Hengge UR Identification and functional characterization of ASK/Dbf4, a novel cell survival gene in cutaneous melanoma with prognostic relevance. Carcinogenesis 2007

 

Mirmohammadsadegh A, Mota R, Gustrau A, Hassan M, Nambiar S, Marini A, Bojar H, Tannapfel A, Hengge UR (2007) ERK1/2 is highly phosphorylated in melanoma metastases and protects melanoma cells from cisplatin-mediated apoptosis. J Invest Dermatol 2007

 

Mota R, Bruch-Gerharz D, Kruse R, Hengge UR Disseminated erythema nodosum Hautarzt 2007;

 

Marini A, Draeger H, Schneider M, Niedermeier A, Hertl M, Ruzicka T, Hengge UR. Rowell syndrome with palmoplantar involvement and suspected epitope spreading. Acta Derm Venereol. 2007

 

2006


Hengge UR, Mota R, Marini A. Frequent and rare dermatological diseases in HIV patients Hautarzt 2006